304 related articles for article (PubMed ID: 22266926)
1. An open system for automatic home-cage behavioral analysis and its application to male and female mouse models of Huntington's disease.
Zarringhalam K; Ka M; Kook YH; Terranova JI; Suh Y; King OD; Um M
Behav Brain Res; 2012 Apr; 229(1):216-25. PubMed ID: 22266926
[TBL] [Abstract][Full Text] [Related]
2. Sex differences in behavior and striatal ascorbate release in the 140 CAG knock-in mouse model of Huntington's disease.
Dorner JL; Miller BR; Barton SJ; Brock TJ; Rebec GV
Behav Brain Res; 2007 Mar; 178(1):90-7. PubMed ID: 17239451
[TBL] [Abstract][Full Text] [Related]
3. Early behavioral deficits in R6/2 mice suitable for use in preclinical drug testing.
Hickey MA; Gallant K; Gross GG; Levine MS; Chesselet MF
Neurobiol Dis; 2005 Oct; 20(1):1-11. PubMed ID: 16137562
[TBL] [Abstract][Full Text] [Related]
4. Increased metabolism in the R6/2 mouse model of Huntington's disease.
van der Burg JM; Bacos K; Wood NI; Lindqvist A; Wierup N; Woodman B; Wamsteeker JI; Smith R; Deierborg T; Kuhar MJ; Bates GP; Mulder H; Erlanson-Albertsson C; Morton AJ; Brundin P; Petersén A; Björkqvist M
Neurobiol Dis; 2008 Jan; 29(1):41-51. PubMed ID: 17920283
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal analysis of the electroencephalogram and sleep phenotype in the R6/2 mouse model of Huntington's disease.
Fisher SP; Black SW; Schwartz MD; Wilk AJ; Chen TM; Lincoln WU; Liu HW; Kilduff TS; Morairty SR
Brain; 2013 Jul; 136(Pt 7):2159-72. PubMed ID: 23801738
[TBL] [Abstract][Full Text] [Related]
6. Detection of early behavioral markers of Huntington's disease in R6/2 mice employing an automated social home cage.
Rudenko O; Tkach V; Berezin V; Bock E
Behav Brain Res; 2009 Nov; 203(2):188-99. PubMed ID: 19410605
[TBL] [Abstract][Full Text] [Related]
7. Force-plate quantification of progressive behavioral deficits in the R6/2 mouse model of Huntington's disease.
Fowler SC; Miller BR; Gaither TW; Johnson MA; Rebec GV
Behav Brain Res; 2009 Aug; 202(1):130-7. PubMed ID: 19447289
[TBL] [Abstract][Full Text] [Related]
8. Effects of chronic stress on the onset and progression of Huntington's disease in transgenic mice.
Mo C; Renoir T; Hannan AJ
Neurobiol Dis; 2014 Nov; 71():81-94. PubMed ID: 25088714
[TBL] [Abstract][Full Text] [Related]
9. Responses to environmental enrichment differ with sex and genotype in a transgenic mouse model of Huntington's disease.
Wood NI; Carta V; Milde S; Skillings EA; McAllister CJ; Ang YL; Duguid A; Wijesuriya N; Afzal SM; Fernandes JX; Leong TW; Morton AJ
PLoS One; 2010 Feb; 5(2):e9077. PubMed ID: 20174443
[TBL] [Abstract][Full Text] [Related]
10. The absence of the aryl hydrocarbon receptor in the R6/1 transgenic mouse model of Huntington's disease improves the neurological phenotype.
Angeles-López QD; García-Lara L; Aguirre-Pineda N; Castañeda-Arellano R; Elizondo-Azuela G; Pérez-Severiano F; Segovia J
Behav Brain Res; 2021 Jun; 408():113230. PubMed ID: 33684424
[TBL] [Abstract][Full Text] [Related]
11. Early exploratory behavior abnormalities in R6/1 Huntington's disease transgenic mice.
Bolivar VJ; Manley K; Messer A
Brain Res; 2004 Apr; 1005(1-2):29-35. PubMed ID: 15044061
[TBL] [Abstract][Full Text] [Related]
12. Chronology of behavioral symptoms and neuropathological sequela in R6/2 Huntington's disease transgenic mice.
Stack EC; Kubilus JK; Smith K; Cormier K; Del Signore SJ; Guelin E; Ryu H; Hersch SM; Ferrante RJ
J Comp Neurol; 2005 Oct; 490(4):354-70. PubMed ID: 16127709
[TBL] [Abstract][Full Text] [Related]
13. Progressive imbalance in the interaction between spatial and procedural memory systems in the R6/2 mouse model of Huntington's disease.
Ciamei A; Morton AJ
Neurobiol Learn Mem; 2009 Oct; 92(3):417-28. PubMed ID: 19524696
[TBL] [Abstract][Full Text] [Related]
14. 'Super-Enrichment' Reveals Dose-Dependent Therapeutic Effects of Environmental Stimulation in a Transgenic Mouse Model of Huntington's Disease.
Mazarakis NK; Mo C; Renoir T; van Dellen A; Deacon R; Blakemore C; Hannan AJ
J Huntingtons Dis; 2014; 3(3):299-309. PubMed ID: 25300333
[TBL] [Abstract][Full Text] [Related]
15. Early retinal function deficit without prominent morphological changes in the R6/2 mouse model of Huntington's disease.
Ragauskas S; Leinonen H; Puranen J; Rönkkö S; Nymark S; Gurevicius K; Lipponen A; Kontkanen O; Puoliväli J; Tanila H; Kalesnykas G
PLoS One; 2014; 9(12):e113317. PubMed ID: 25469887
[TBL] [Abstract][Full Text] [Related]
16. Dopamine release is severely compromised in the R6/2 mouse model of Huntington's disease.
Johnson MA; Rajan V; Miller CE; Wightman RM
J Neurochem; 2006 May; 97(3):737-46. PubMed ID: 16573654
[TBL] [Abstract][Full Text] [Related]
17. Extensive early motor and non-motor behavioral deficits are followed by striatal neuronal loss in knock-in Huntington's disease mice.
Hickey MA; Kosmalska A; Enayati J; Cohen R; Zeitlin S; Levine MS; Chesselet MF
Neuroscience; 2008 Nov; 157(1):280-95. PubMed ID: 18805465
[TBL] [Abstract][Full Text] [Related]
18. Corticosterone dysregulation exacerbates disease progression in the R6/2 transgenic mouse model of Huntington's disease.
Dufour BD; McBride JL
Exp Neurol; 2016 Sep; 283(Pt A):308-17. PubMed ID: 27381424
[TBL] [Abstract][Full Text] [Related]
19. The detection and measurement of locomotor deficits in a transgenic mouse model of Huntington's disease are task- and protocol-dependent: influence of non-motor factors on locomotor function.
Pallier PN; Drew CJ; Morton AJ
Brain Res Bull; 2009 Mar; 78(6):347-55. PubMed ID: 19010400
[TBL] [Abstract][Full Text] [Related]
20. Depletion of rabphilin 3A in a transgenic mouse model (R6/1) of Huntington's disease, a possible culprit in synaptic dysfunction.
Smith R; Petersén A; Bates GP; Brundin P; Li JY
Neurobiol Dis; 2005 Dec; 20(3):673-84. PubMed ID: 15967669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
